Global Measle Vaccine Market Growth 2022-2028
- LP 4754471
- 73 Pages
- January 2022
- Pharmaceuticals
The United States Measle Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Measle Vaccine market, reaching US$ million by the year 2028. As for the Europe Measle Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Measle Vaccine players cover Merck, Biovac, McKesson Medical, and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Measle Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Inactivated Vaccine
Attenuated Vaccine
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Scientific Research
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Merck
Biovac
McKesson Medical
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Measle Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Measle Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Measle Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Measle Vaccine Segment by Type
2.2.1 Inactivated Vaccine
2.2.2 Attenuated Vaccine
2.3 Measle Vaccine Sales by Type
2.3.1 Global Measle Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Measle Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Measle Vaccine Sale Price by Type (2017-2022)
2.4 Measle Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Scientific Research
2.4.3 Others
2.5 Measle Vaccine Sales by Application
2.5.1 Global Measle Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Measle Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Measle Vaccine Sale Price by Application (2017-2022)
3 Global Measle Vaccine by Company
3.1 Global Measle Vaccine Breakdown Data by Company
3.1.1 Global Measle Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Measle Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Measle Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Measle Vaccine Revenue by Company (2020-2022)
3.2.2 Global Measle Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Measle Vaccine Sale Price by Company
3.4 Key Manufacturers Measle Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Measle Vaccine Product Location Distribution
3.4.2 Players Measle Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Measle Vaccine by Geographic Region
4.1 World Historic Measle Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Measle Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Measle Vaccine Annual Revenue by Geographic Region
4.2 World Historic Measle Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Measle Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Measle Vaccine Annual Revenue by Country/Region
4.3 Americas Measle Vaccine Sales Growth
4.4 APAC Measle Vaccine Sales Growth
4.5 Europe Measle Vaccine Sales Growth
4.6 Middle East & Africa Measle Vaccine Sales Growth
5 Americas
5.1 Americas Measle Vaccine Sales by Country
5.1.1 Americas Measle Vaccine Sales by Country (2017-2022)
5.1.2 Americas Measle Vaccine Revenue by Country (2017-2022)
5.2 Americas Measle Vaccine Sales by Type
5.3 Americas Measle Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Measle Vaccine Sales by Region
6.1.1 APAC Measle Vaccine Sales by Region (2017-2022)
6.1.2 APAC Measle Vaccine Revenue by Region (2017-2022)
6.2 APAC Measle Vaccine Sales by Type
6.3 APAC Measle Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Measle Vaccine by Country
7.1.1 Europe Measle Vaccine Sales by Country (2017-2022)
7.1.2 Europe Measle Vaccine Revenue by Country (2017-2022)
7.2 Europe Measle Vaccine Sales by Type
7.3 Europe Measle Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Measle Vaccine by Country
8.1.1 Middle East & Africa Measle Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Measle Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Measle Vaccine Sales by Type
8.3 Middle East & Africa Measle Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Measle Vaccine
10.3 Manufacturing Process Analysis of Measle Vaccine
10.4 Industry Chain Structure of Measle Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Measle Vaccine Distributors
11.3 Measle Vaccine Customer
12 World Forecast Review for Measle Vaccine by Geographic Region
12.1 Global Measle Vaccine Market Size Forecast by Region
12.1.1 Global Measle Vaccine Forecast by Region (2023-2028)
12.1.2 Global Measle Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Measle Vaccine Forecast by Type
12.7 Global Measle Vaccine Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Measle Vaccine Product Offered
13.1.3 Merck Measle Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Biovac
13.2.1 Biovac Company Information
13.2.2 Biovac Measle Vaccine Product Offered
13.2.3 Biovac Measle Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Biovac Main Business Overview
13.2.5 Biovac Latest Developments
13.3 McKesson Medical
13.3.1 McKesson Medical Company Information
13.3.2 McKesson Medical Measle Vaccine Product Offered
13.3.3 McKesson Medical Measle Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 McKesson Medical Main Business Overview
13.3.5 McKesson Medical Latest Developments
14 Research Findings and Conclusion
Table 1. Measle Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Measle Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Inactivated Vaccine
Table 4. Major Players of Attenuated Vaccine
Table 5. Global Measle Vaccine Sales by Type (2017-2022) & (K Units)
Table 6. Global Measle Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global Measle Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Measle Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global Measle Vaccine Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Measle Vaccine Sales by Application (2017-2022) & (K Units)
Table 11. Global Measle Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global Measle Vaccine Revenue by Application (2017-2022)
Table 13. Global Measle Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global Measle Vaccine Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Measle Vaccine Sales by Company (2020-2022) & (K Units)
Table 16. Global Measle Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global Measle Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Measle Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global Measle Vaccine Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Measle Vaccine Producing Area Distribution and Sales Area
Table 21. Players Measle Vaccine Products Offered
Table 22. Measle Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Measle Vaccine Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Measle Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Measle Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Measle Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Measle Vaccine Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Measle Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Measle Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Measle Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Measle Vaccine Sales by Country (2017-2022) & (K Units)
Table 34. Americas Measle Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas Measle Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Measle Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas Measle Vaccine Sales by Type (2017-2022) & (K Units)
Table 38. Americas Measle Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas Measle Vaccine Sales by Application (2017-2022) & (K Units)
Table 40. Americas Measle Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC Measle Vaccine Sales by Region (2017-2022) & (K Units)
Table 42. APAC Measle Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC Measle Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Measle Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC Measle Vaccine Sales by Type (2017-2022) & (K Units)
Table 46. APAC Measle Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC Measle Vaccine Sales by Application (2017-2022) & (K Units)
Table 48. APAC Measle Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe Measle Vaccine Sales by Country (2017-2022) & (K Units)
Table 50. Europe Measle Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe Measle Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Measle Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe Measle Vaccine Sales by Type (2017-2022) & (K Units)
Table 54. Europe Measle Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe Measle Vaccine Sales by Application (2017-2022) & (K Units)
Table 56. Europe Measle Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Measle Vaccine Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Measle Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Measle Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Measle Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Measle Vaccine Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Measle Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Measle Vaccine Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Measle Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Measle Vaccine
Table 66. Key Market Challenges & Risks of Measle Vaccine
Table 67. Key Industry Trends of Measle Vaccine
Table 68. Measle Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Measle Vaccine Distributors List
Table 71. Measle Vaccine Customer List
Table 72. Global Measle Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Measle Vaccine Sales Market Forecast by Region
Table 74. Global Measle Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Measle Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Measle Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Measle Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Measle Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Measle Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Measle Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Measle Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Measle Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Measle Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Measle Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Measle Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Measle Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Measle Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Measle Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Measle Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Measle Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Measle Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. Merck Basic Information, Measle Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Merck Measle Vaccine Product Offered
Table 94. Merck Measle Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Merck Main Business
Table 96. Merck Latest Developments
Table 97. Biovac Basic Information, Measle Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Biovac Measle Vaccine Product Offered
Table 99. Biovac Measle Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Biovac Main Business
Table 101. Biovac Latest Developments
Table 102. McKesson Medical Basic Information, Measle Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. McKesson Medical Measle Vaccine Product Offered
Table 104. McKesson Medical Measle Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. McKesson Medical Main Business
Table 106. McKesson Medical Latest Developments
List of Figures
Figure 1. Picture of Measle Vaccine
Figure 2. Measle Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Measle Vaccine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Measle Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Measle Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Inactivated Vaccine
Figure 10. Product Picture of Attenuated Vaccine
Figure 11. Global Measle Vaccine Sales Market Share by Type in 2021
Figure 12. Global Measle Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. Measle Vaccine Consumed in Hospital
Figure 14. Global Measle Vaccine Market: Hospital (2017-2022) & (K Units)
Figure 15. Measle Vaccine Consumed in Scientific Research
Figure 16. Global Measle Vaccine Market: Scientific Research (2017-2022) & (K Units)
Figure 17. Measle Vaccine Consumed in Others
Figure 18. Global Measle Vaccine Market: Others (2017-2022) & (K Units)
Figure 19. Global Measle Vaccine Sales Market Share by Application (2017-2022)
Figure 20. Global Measle Vaccine Revenue Market Share by Application in 2021
Figure 21. Measle Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Measle Vaccine Revenue Market Share by Company in 2021
Figure 23. Global Measle Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Measle Vaccine Revenue Market Share by Geographic Region in 2021
Figure 25. Global Measle Vaccine Sales Market Share by Region (2017-2022)
Figure 26. Global Measle Vaccine Revenue Market Share by Country/Region in 2021
Figure 27. Americas Measle Vaccine Sales 2017-2022 (K Units)
Figure 28. Americas Measle Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. APAC Measle Vaccine Sales 2017-2022 (K Units)
Figure 30. APAC Measle Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Europe Measle Vaccine Sales 2017-2022 (K Units)
Figure 32. Europe Measle Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Measle Vaccine Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Measle Vaccine Revenue 2017-2022 ($ Millions)
Figure 35. Americas Measle Vaccine Sales Market Share by Country in 2021
Figure 36. Americas Measle Vaccine Revenue Market Share by Country in 2021
Figure 37. United States Measle Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Measle Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Measle Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Measle Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Measle Vaccine Sales Market Share by Region in 2021
Figure 42. APAC Measle Vaccine Revenue Market Share by Regions in 2021
Figure 43. China Measle Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Measle Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Measle Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Measle Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Measle Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Measle Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Measle Vaccine Sales Market Share by Country in 2021
Figure 50. Europe Measle Vaccine Revenue Market Share by Country in 2021
Figure 51. Germany Measle Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Measle Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Measle Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Measle Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Measle Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Measle Vaccine Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Measle Vaccine Revenue Market Share by Country in 2021
Figure 58. Egypt Measle Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Measle Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Measle Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Measle Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Measle Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Measle Vaccine in 2021
Figure 64. Manufacturing Process Analysis of Measle Vaccine
Figure 65. Industry Chain Structure of Measle Vaccine
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
